Jundishapur Journal of Microbiology

Published by: Kowsar

The Prevalence and Genotype Distribution of Human Papillomavirus Types in the General Female Population in West of Iran

Somayeh Jalilian 1 , Babak Izadi 2 , Seyed Hamid Madani 2 and Parviz Mohajeri 3 , *
Authors Information
1 Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
2 Molecular Pathology Research Center, Emam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2017, 10 (3); e40855
  • Published Online: February 6, 2017
  • Article Type: Research Article
  • Received: July 16, 2016
  • Revised: January 17, 2017
  • Accepted: January 25, 2017
  • DOI: 10.5812/jjm.40855

To Cite: Jalilian S, Izadi B, Madani S H, Mohajeri P. The Prevalence and Genotype Distribution of Human Papillomavirus Types in the General Female Population in West of Iran, Jundishapur J Microbiol. 2017 ; 10(3):e40855. doi: 10.5812/jjm.40855.

Copyright © 2017, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Schiffman M, Wentzensen N. From human papillomavirus to cervical cancer. Obstet Gynecol. 2010; 116(1): 177-85[DOI][PubMed]
  • 2. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013; 40(3): 187-93[DOI][PubMed]
  • 3. Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014; 41(11): 660-4[DOI][PubMed]
  • 4. Cervical cancer, human papillomavirus (HPV), and HPV vaccines: Key points for policy-makers and health professionals . 2007;
  • 5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-917[DOI][PubMed]
  • 6. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49(6): 1374-403[DOI][PubMed]
  • 7. Shafaghi B, Jarollahi A, Yousefzadeh B, Ameri A, Moghadam S, Mostafavi M. Human Papilloma Virus Prevalence and Types among Iranian Women Attending Regular Gynecological visits. Rep Radiother Oncol. 2013; 1(2): 73-9
  • 8. Gross G. Genitoanal human papillomavirus infection and associated neoplasias. Curr Probl Dermatol. 2014; 45: 98-122[DOI][PubMed]
  • 9. Szostek S, Klimek M, Zawilinska B, Rys J, Kope J, Daszkiewic E. Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers. Acta Biochim Pol. 2006; 53(3): 603-7[PubMed]
  • 10. Gross G, Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol. 2004; 193(1): 35-44[DOI][PubMed]
  • 11. Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol. 2008; 46(1): 109-17[DOI][PubMed]
  • 12. Chan PK, Picconi MA, Cheung TH, Giovannelli L, Park JS. Laboratory and clinical aspects of human papillomavirus testing. Crit Rev Clin Lab Sci. 2012; 49(4): 117-36[DOI][PubMed]
  • 13. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012; 30 Suppl 5-70[DOI][PubMed]
  • 14. Szarewski A. Prophylactic vaccines for human papillomavirus: a bright future for cervical cancer prevention. J Med Screen. 2005; 12(4): 163-5[DOI][PubMed]
  • 15. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005; 366(9490): 991-8[DOI][PubMed]
  • 16. Akil N, Yasmeen A, Kassab A, Ghabreau L, Darnel AD, Al Moustafa AE. High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer. 2008; 99(3): 404-7[DOI][PubMed]
  • 17. Bruni L, BarrionuevoRosas L, Albero G. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 2015 04 08. 2014;
  • 18. Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics. 2009; 12(5-6): 291-307[DOI][PubMed]
  • 19. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003; 16(1): 1-17[PubMed]
  • 20. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009; 10(4): 321-2[PubMed]
  • 21. WHO/ICO Information Centre on HPV and Cervical cancer. 2008;
  • 22. Ghaffari SR, Sabokbar T, Mollahajian H, Dastan J, Ramezanzadeh F, Ensani F, et al. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev. 2006; 7(4): 529-32[PubMed]
  • 23. Bao YP, Li N, Smith JS, Qiao YL, Accpab members . Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer. 2008; 18(1): 71-9[DOI][PubMed]
  • 24. Zandi K, Eghbali SS, Hamkar R, Ahmadi S, Ramedani E, Deilami I, et al. Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009. Virol J. 2010; 7: 65[DOI][PubMed]
  • 25. Shahramian I, Heidari Z, Mahmoudzadeh-Sagheb H, Moradi A, Forghani F. Prevalence of HPV Infection and High Risk HPV Genotypes (16, 18), among Monogamous and Polygamous Women, In Zabol, Iran. Iran J Public Health. 2011; 40(3): 113-21[PubMed]
  • 26. Khorasanizadeh F, Hassanloo J, Khaksar N, Mohammad Taheri S, Marzaban M, H. Rashidi B , et al. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature. Gynecol Oncol. 2013; 128(2): 277-81[DOI][PubMed]
  • 27. Zhao C, Elishaev E, Yuan KH, Yu J, Austin RM. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests. Cancer. 2007; 111(5): 292-7[DOI][PubMed]
  • 28. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001; 285(23): 2995-3002[PubMed]
  • 29. The Weekly Epidemiological Record (WER). 2014;
  • 30. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010; 202(12): 1789-99[DOI][PubMed]
  • 31. Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, et al. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. Int J Cancer. 2012; 130(9): 2111-7[DOI][PubMed]
  • 32. Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, et al. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda. Sex Transm Infect. 2008; 84(4): 306-11[DOI][PubMed]
  • 33. Castellsague X, Menendez C, Loscertales MP, Kornegay JR, dos Santos F, Gomez-Olive FX, et al. Human papillomavirus genotypes in rural Mozambique. Lancet. 2001; 358(9291): 1429-30[DOI][PubMed]
  • 34. De Vuyst H, Clifford G, Li N, Franceschi S. HPV infection in Europe. Eur J Cancer. 2009; 45(15): 2632-9[DOI][PubMed]
  • 35. Daneshvar F, Haghshenas M, Majleci F, Rahimi A. The Prevalence and Genotype Distribution of Cervical Human Papillomavirus DNA in Women with Normal Cytology in North of Iran. Jundishapur J Microbiol. 2016; 10(1)[DOI]
  • 36. Salehi-Vaziri M, Sadeghi F, Hashemi FS, Haeri H, Bokharaei-Salim F, Monavari SH, et al. Distribution of Human Papillomavirus Genotypes in Iranian Women According to the Severity of the Cervical Lesion. Iran Red Crescent Med J. 2016; 18(4)[DOI][PubMed]
  • 37. Lin H, Ma YY, Moh JS, Ou YC, Shen SY, ChangChien CC. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol. 2006; 101(1): 40-5[DOI][PubMed]
  • 38. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, et al. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer. 2007; 121(6): 1306-11[DOI][PubMed]
  • 39. Alsbeih G, Ahmed R, Al-Harbi N, Venturina LA, Tulbah A, Balaraj K. Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia. Gynecol Oncol. 2011; 121(3): 522-6[DOI][PubMed]
  • 40. Sun LL, Jin Q, Li H, Zhou XR, Song ZQ, Cheng XM, et al. Population-based study on the prevalence of and risk factors for human papillomavirus infection in Qujing of Yunnan province, Southwest China. Virol J. 2012; 9: 153[DOI][PubMed]
  • 41. von Krogh G, Lacey CJ, Gross G, Barrasso R, Schneider A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect. 2000; 76(3): 162-8[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments